PhoenixBio Co.,Ltd.JP:6190
| Mar 31,
2015 | Mar 31,
2016 | Mar 31,
2017 | Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 | Mar 31,
2021 | Mar 31,
2022 | Mar 31,
2023 | Mar 31,
2024 |
|---|
| Profit (loss) before income taxes | 63 | 147 | 130 | -267 | -295 | -418 | -224 | -393 | 511 | 60 |
|---|
| Depreciation | 22 | 22 | 25 | 24 | 30 | 53 | 55 | 86 | 24 | 25 |
|---|
| Impairment losses | - | - | - | - | 15 | 292 | - | 265 | - | 1 |
|---|
| Share-based payment expenses | - | - | - | 24 | 21 | 12 | 12 | 16 | 19 | 29 |
|---|
| Increase (decrease) in provision for bonuses | - | - | - | - | - | - | - | - | 5 | 3 |
|---|
| Increase (decrease) in allowance for doubtful accounts | - | - | - | - | - | - | - | - | - | 7 |
|---|
| Interest income | -0 | -0 | -9 | -0 | -1 | -1 | -1 | -0 | -2 | -6 |
|---|
| Interest expenses | 3 | 3 | 2 | 2 | 1 | 2 | 1 | 1 | 3 | 3 |
|---|
| Foreign exchange losses (gains) | -12 | 29 | 23 | -4 | -14 | 1 | -6 | -6 | -6 | -4 |
|---|
| Subsidy income | - | - | -3 | -0 | -24 | -31 | -16 | -10 | -9 | -16 |
|---|
| Loss on retirement of property, plant and equipment | 0 | 0 | - | 0 | 1 | 0 | - | 0 | 1 | 0 |
|---|
| Loss (gain) on redemption of investment securities | - | - | - | - | - | - | - | - | - | -17 |
|---|
| Gain on reversal of share acquisition rights | - | - | - | - | - | - | - | - | - | -0 |
|---|
| Decrease (increase) in accounts receivable - trade, and contract assets | - | - | - | - | - | - | - | - | -60 | 69 |
|---|
| Decrease (increase) in inventories | -57 | -20 | 37 | -31 | 17 | -50 | -56 | -19 | -106 | -83 |
|---|
| Increase (decrease) in trade payables | -20 | 21 | -19 | 9 | 7 | 1 | 8 | -5 | 2 | -27 |
|---|
| Increase (decrease) in accounts payable - other | -14 | 16 | -13 | 3 | 40 | -0 | -39 | 19 | 13 | -12 |
|---|
| Increase (decrease) in advances received | -7 | 26 | -45 | 52 | 49 | 29 | 103 | 101 | -201 | 11 |
|---|
| Increase (decrease) in deposits received | - | - | - | - | - | - | - | 5 | 84 | -87 |
|---|
| Other, net | -35 | 52 | 8 | -10 | 48 | 3 | -6 | 8 | 1 | 4 |
|---|
| Subtotal | 6 | 272 | 61 | -189 | -180 | -43 | -129 | 13 | 277 | -41 |
|---|
| Interest and dividends received | 0 | 0 | 9 | 0 | 1 | 1 | 1 | 0 | 2 | 6 |
|---|
| Interest paid | -3 | -3 | -2 | -2 | -1 | -2 | -1 | -1 | -3 | -3 |
|---|
| Subsidies received | - | - | 1 | 2 | 21 | 33 | 15 | 7 | 13 | 8 |
|---|
| Income taxes paid | -11 | -8 | -25 | -3 | -2 | -2 | -3 | -4 | -12 | -49 |
|---|
| Income taxes refund | - | - | - | 4 | 2 | 0 | 0 | 0 | 0 | - |
|---|
| Net cash provided by (used in) operating activities | -8 | 259 | 45 | -187 | -160 | -13 | -102 | 16 | 277 | -79 |
|---|
| Purchase of securities | - | - | - | - | - | - | - | - | - | -0 |
|---|
| Purchase of property, plant and equipment | -8 | -18 | -10 | -5 | -64 | -31 | -181 | -7 | -7 | -32 |
|---|
| Purchase of intangible assets | - | -2 | - | -2 | -2 | - | -1 | - | -6 | -7 |
|---|
| Purchase of investment securities | - | - | - | - | - | - | - | - | -136 | -9 |
|---|
| Proceeds from redemption of investment securities | - | - | - | - | - | - | - | - | - | 153 |
|---|
| Other, net | 0 | -4 | - | -1 | 1 | 0 | -2 | -0 | -8 | 10 |
|---|
| Net cash provided by (used in) investing activities | 6 | -137 | 99 | -452 | -65 | -16 | -185 | -7 | -156 | 115 |
|---|
| Net increase (decrease) in short-term borrowings | -100 | - | - | - | - | 200 | -200 | - | - | 100 |
|---|
| Proceeds from long-term borrowings | 100 | - | 208 | - | - | - | - | - | - | 400 |
|---|
| Repayments of long-term borrowings | -50 | -53 | -184 | -56 | -56 | -26 | -20 | -2 | - | -20 |
|---|
| Redemption of convertible bond-type bonds with subscription rights to shares | - | - | - | - | - | - | - | - | - | -725 |
|---|
| Repayments of lease liabilities | -3 | -1 | -2 | -4 | -5 | -25 | -21 | -30 | -56 | -38 |
|---|
| Proceeds from issuance of shares resulting from exercise of share acquisition rights | - | - | - | - | - | - | 85 | - | 143 | 38 |
|---|
| Net cash provided by (used in) financing activities | 46 | 735 | 20 | -63 | -65 | 1,146 | -160 | -35 | 87 | -245 |
|---|
| Effect of exchange rate change on cash and cash equivalents | 10 | -34 | -20 | -1 | 13 | 1 | -1 | 23 | 22 | 38 |
|---|
| Net increase (decrease) in cash and cash equivalents | 55 | 823 | 144 | -702 | -276 | 1,119 | -448 | -2 | 230 | -170 |
|---|